Study in measurement of hardness of the intracranial hematoma

Study in measurement of hardness of the intracranial hematoma - Study in measurement of hardness of the intracranial hematoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026037

Enrollment

Registered

2017-02-07

Start date

2017-02-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial hematoma

Interventions

measurement of hardness of hematoma one time at surgery antithrombotic therapy medicine, dose, period are not concerned

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with intracranial hematoma Patients with written agreement for the study by him/herself or a family member under the free will after the sufficient understanding after the explanation

Exclusion criteria

Exclusion criteria: Patients whom the study chief or assistants decided not to be optimal to include the study

Design outcomes

Primary

Measure	Time frame
Intracranial hematoma of the patients with antithrombotic therapy is hard.	—

Secondary

Measure	Time frame
Hematoma histology, safeness of surgery, neurological outcome	—

Countries

Japan

Contacts

Public ContactSadahiro Nomura

Yamaguchi Graduate School of Medicine Neurosurgery

snomura@yamaguchi-u.ac.jp0836-22-2295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026